CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Hellmann Worldwide Logistics

David Bang, Global Vice President Strategic Development

Data Connectivity and Collaboration in Life Sciences and Healthcare Supply Chain

David Bang

David Bang

I’ve just sent a prescription to your local pharmacy. Let’s follow up in a week, and your app will remind you.” “Thank you, Doctor Williams,” says John, who just used the app to get a virtual medical consultation without having to leave his living room. No waiting time, no co-pay. This is now a common example of healthcare consumerism, one of the industry forces that are profoundly changing the landscape.


Through healthcare consumerism, access to healthcare is becoming more like an eCommerce shopping experience. According to the 2017 McKinsey Consumer Health Insight Survey, more than 70% of the respondents said digital solutions are preferred for maintaining health, selecting a provider, and even receiving care. That’s why companies like Merck KGaA (unaffiliated with Merck & Co.) have been automating its demand planning using Artificial Intelligence (AI) since 2017.


When the demand planning is automated, you must wonder about the supply side as well. Making sure products get to patients via various channels is equally critical. When I recently spoke to a handful of life sciences and healthcare executives in the San Francisco area, the common theme was that the industry still has too many siloes of data.


For example, the primary ways of selecting and qualifying temperature[1]controlled packaging (TCP) and setting up and running logistics have not made any significant technological advancement over the last two decades. Yes, maybe some incremental improvements were made here and there, and some credits are due to profound industry efforts on regulatory compliance issues. 


However, eventually not being able to automate things on the supply side will catch up with us to cause even more issues down the road. Imagine when personalized medicines become more like the 23andMe process. How will we ensure the absolute accuracy, flexibility, and compliance at each patient delivery level?


"I believe that at least we should start with three essential data types that the industry needs to start breaking down the siloes on: time, temperature, and physical handling"


I believe that at least we should start with three essential data types that the industry needs to start breaking down the siloes on: time, temperature, and physical handling. What if these data types freely and securely flow among life sciences and healthcare manufacturers, 3PLs, temperature-controlled packaging, data logger and IoT, and IT platform companies? Here are a couple of actual positive examples of how such broken siloes can benefit the industry. One example is that based on the thermal energy left inside of the TCP depending on ambient conditions, the system knows how many hours left to go in real-time, and with deep integration with a 3PL, it intelligently initiates contingency actions without depending on human reactions. Another exciting example is with a CAPA (Corrective and Preventive Action) management that gets raised automatically based on pre[1]determined criteria with automated process management and control instead of relying solely on individual parties’ subsequent actions.


Although there are some naysayers, the market is big enough for everyone, and the benefits of connectivity far weigh the potential concerns about perceived proprietary knowledge. Indeed, it is about time for the collective will of like-minded leaders to make the movement, which I gladly invite you to.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://clinical-stage-biopharmaceutical.lifesciencesreview.com/leadership-perspective/data-connectivity-and-collaboration-in-life-sciences-and-healthcare-supply-chain-nwid-768.html